Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Agut

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
The American Journal of Cardiology|August 18, 2000
Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarctionR Choussat, G Montalescot, J Collet, et al.
Presse Medicale (Paris, France : 1983)|March 27, 1999
[Immunologic reconstruction after antiretroviral treatment]R Tubiana, G Carcelain, H A Mohand, et al.
AIDS (London, England)|October 31, 2001
Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failureC Delaugerre, M A Valantin, M Mouroux, et al.
Pathologie-Biologie|July 27, 1999
[Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor]M Mouroux, P Bossi, A Yvon-Groussin, et al.
Annals of Internal Medicine|October 3, 1998
Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infectionC Katlama, M A Valantin, S Matheron, et al.
Pathologie-Biologie|August 19, 2000
[Conditions of "thymidine analog mutations" (TAMs) in naive patients treated with different combinations of d4T]M Mouroux, J Izopet, D Descamps, et al.
Antiviral Therapy|January 26, 2002
Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapyM Mouroux, D Descamps, J Izopet, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
The American Journal of Cardiology|August 18, 2000
Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarctionR Choussat, G Montalescot, J Collet, et al.
Presse Medicale (Paris, France : 1983)|March 27, 1999
[Immunologic reconstruction after antiretroviral treatment]R Tubiana, G Carcelain, H A Mohand, et al.
AIDS (London, England)|October 31, 2001
Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failureC Delaugerre, M A Valantin, M Mouroux, et al.
Pathologie-Biologie|July 27, 1999
[Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor]M Mouroux, P Bossi, A Yvon-Groussin, et al.
Annals of Internal Medicine|October 3, 1998
Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infectionC Katlama, M A Valantin, S Matheron, et al.
Pathologie-Biologie|August 19, 2000
[Conditions of "thymidine analog mutations" (TAMs) in naive patients treated with different combinations of d4T]M Mouroux, J Izopet, D Descamps, et al.
Antiviral Therapy|January 26, 2002
Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapyM Mouroux, D Descamps, J Izopet, et al.
Pageof 15